Pharmacokinetic and Clinical Observations in People over Fifty
Design and Objective
The purpose of this study is to identify medical conditions that may cause particular problems to individuals receiving care for HIV infection over the age of 50. Results from this study may inform future HIV treatment guidelines on how we monitor individuals with HIV infection. The results may also assist in the design of future studies for the treatment of diseases associated with ageing.
Key inclusion criteria
HIV-positive cohort Documented HIV infection, aged 18 years or above, from a white or black ethnic background. HIV-negative cohort HIV-negative persons aged 50 years or above, from a white or black ethnic background.